US Patent

US9421333 — Hazardous agent injection system

Method of Use · Assigned to Antares Pharma Inc · Expires 2030-03-19 · 4y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a system for injecting hazardous agents, including a powered injector.

USPTO Abstract

Injection systems comprising a powered injector and one or more hazardous agents are disclosed.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259
U-1442 — chembl-chembl34259

Patent Metadata

Patent number
US9421333
Jurisdiction
US
Classification
Method of Use
Expires
2030-03-19
Drug substance claim
No
Drug product claim
Yes
Assignee
Antares Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.